| A majority of low (1-10%) ER positive breast cancers behave like hormone receptor negative tumors JS Prabhu, A Korlimarla, K Desai, A Alexander, R Raghavan, ... Journal of Cancer 5 (2), 156, 2014 | 121 | 2014 |
| The impact of breast cancer on the patient and the family in Indian perspective A Alexander, R Kaluve, JS Prabhu, A Korlimarla, BS Srinath, S Manjunath, ... Indian journal of palliative care 25 (1), 66, 2019 | 76 | 2019 |
| High expression of integrin β6 in association with the Rho–Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers K Desai, MG Nair, JS Prabhu, A Vinod, A Korlimarla, S Rajarajan, ... Cancer medicine 5 (8), 2000-2011, 2016 | 39 | 2016 |
| miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis MG Nair, JS Prabhu, A Korlimarla, S Rajarajan, H PS, R Kaul, ... Cancer Medicine 9 (15), 5587-5597, 2020 | 24 | 2020 |
| HR+ HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells K Desai, R Aiyappa, JS Prabhu, MG Nair, PV Lawrence, A Korlimarla, ... Tumor Biology 39 (3), 1010428317695028, 2017 | 16 | 2017 |
| Progress in psycho-oncology with special reference to developing countries RS Murthy, A Alexander Current Opinion in Psychiatry 32 (5), 442-450, 2019 | 11 | 2019 |
| Pattern of external breast prosthesis use by post mastectomy breast cancer patients in India: Descriptive study from tertiary care centre D Ramu, RS Ramesh, S Manjunath, Shivakumar, V Goel, GN Hemnath, ... Indian journal of surgical oncology 6 (4), 374-377, 2015 | 11 | 2015 |
| Dissecting the biological heterogeneity within hormone receptor positive HER2 negative breast cancer by gene expression markers identifies indolent tumors within late stage disease JS Prabhu, A Korlimarla, CE Anupama, A Alexander, R Raghavan, R Kaul, ... Translational Oncology 10 (4), 699-706, 2017 | 9 | 2017 |
| Pre-menopausal women with breast cancers having high AR/ER ratios in the context of higher circulating testosterone tend to have poorer outcomes S Rajarajan, A Korlimarla, A Alexander, CE Anupama, R Ramesh, ... Frontiers in Endocrinology 12, 679756, 2021 | 8 | 2021 |
| Living with cancer: Urgent need for emotional health support A Alexander, RS Murthy Indian Journal of Cancer 57 (3), 360-362, 2020 | 7 | 2020 |
| Beyond numbers–recent understanding of emotional needs of persons diagnosed with cancer 2007–2018 A Alexander, K Sreenath, RS Murthy Indian Journal of Palliative Care 26 (1), 120, 2020 | 7 | 2020 |
| An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers S Rajarajan, VP Snijesh, CE Anupama, MG Nair, AD Mavatkar, CM Naidu, ... Translational Oncology 37, 101761, 2023 | 5 | 2023 |
| Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis VP Nimbalkar, VP Snijesh, S Rajarajan, A Alexander, R Kaluve, ... Breast Cancer Research and Treatment 200 (1), 139-149, 2023 | 5 | 2023 |
| A comparative analysis of clinicopathological features and survival between pre and postmenopausal breast cancer from an Indian cohort VP Nimbalkar, S Rajarajan, S VP, A Alexander, R Kaluve, S Selvam, ... Scientific Reports 13 (1), 3938, 2023 | 5 | 2023 |
| 38P Triple-negative breast cancers with expression of glucocorticoid receptor in immune cells show better prognosis JS Prabhu, S Patil, S Rajarajan, A Ce, M Nair, A Alexander, R Ramesh, ... Annals of Oncology 32, S35, 2021 | 5 | 2021 |
| Abstract P4-10-12: Treatment decision making, and strategies for coping with financial stress in Indian women diagnosed with breast cancer and their families A Alexander, R Kaluve, JS Prabhu, A Korlimarla, S BS, S Manjunath, ... Cancer Research 78 (4_Supplement), P4-10-12-P4-10-12, 2018 | 5 | 2018 |
| Abstract PS6-55: The prognostic utility of AR/ER ratio in young women with breast cancer JS Prabhu, A Korlimarla, S Rajarajan, A Alexander, C Anupama, ... Cancer research 81 (4_Supplement), PS6-55-PS6-55, 2021 | 3 | 2021 |
| Spatial Profiling Reveals Distinct Immune Microenvironment Specific to Premenopausal Triple Negative Breast Cancer VP Nimbalkar, VP Snijesh, S Rajarajan, CE Anupama, S Mahalakshmi, ... | | 2024 |
| Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes VP Snijesh, VP Nimbalkar, S Patil, S Rajarajan, CE Anupama, ... Translational Oncology 45, 101957, 2024 | | 2024 |
| Endurance and Evolution: Exploring Levels of Resilience Among Indian Breast Cancer Survivors A Alexander, S Kuruveettissery, RS Ramesh, BS Srinath, S Appachu, ... Illness, Crisis & Loss, 10541373241260157, 2024 | | 2024 |
Jyothi PrabhuDBT-Wellcome Trust India Alliance Intermediate Fellow, St Johns Research InstituteGeverifieerd e-mailadres voor sjri.res.in